We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

dinsdag 28 november 2017

The Pharmacogenomics Journal - Table of Contents alert Volume 17 Issue 6

If you are unable to see the message below, click here to view.
The Pharmacogenomics Journal
 
TABLE OF CONTENTS

Volume 17, Issue 6 (December 2017)

In this issue
Letter to the Editor
Review
Original Articles
Retraction

Also new
AOP
 
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
 

Letter to the Editor

Top

HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients

M Frías, D Rodríguez-Cano, F Cuenca-López, J Macías, A Gordon, B Manzanares-Martín, J A Pineda, Á Camacho, J Torre-Cisneros, J Peña, A Rivero-Juárez and A Rivero

Pharmacogenomics J 2017 17: 479-480; advance online publication, October 25, 2016; 10.1038/tpj.2016.80

Full Text

Review

Top

CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health

A Prytuła, K Cransberg and A Raes

Pharmacogenomics J 2017 17: 481-487; advance online publication, April 18, 2017; 10.1038/tpj.2017.15

Abstract | Full Text

Original Articles

Top

Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics

J Reis-Pardal, A Rodrigues, E Rodrigues and F Fernandez-Llimos

Pharmacogenomics J 2017 17: 488-493; advance online publication, May 31, 2016; 10.1038/tpj.2016.40

Abstract | Full Text

Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms

K Kubo, M Ohara, M Tachikawa, L H Cavallari, M T M Lee, M S Wen, M G Scordo, E A Nutescu, M A Perera, A Miyajima, N Kaneko, V Pengo, R Padrini, Y T Chen and H Takahashi

Pharmacogenomics J 2017 17: 494-500; advance online publication, August 9, 2016; 10.1038/tpj.2016.57

Abstract | Full Text

HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions

Y Yang, S Chen, F Yang, L Zhang, G Alterovitz, H Zhu, J Xuan, X Yang, H Luo, J Mu, L He, X Luo and Q Xing

Pharmacogenomics J 2017 17: 501-505; advance online publication, August 16, 2016; 10.1038/tpj.2016.61

Abstract | Full Text

Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy

S Pontikakis, C Papadaki, M Tzardi, M Trypaki, M Sfakianaki, F Koinis, E Lagoudaki, L Giannikaki, A Kalykaki, E Kontopodis, Z Saridaki, N Malamos, V Georgoulias and J Souglakos

Pharmacogenomics J 2017 17: 506-514; advance online publication, October 25, 2016; 10.1038/tpj.2016.63

Abstract | Full Text

Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin

T F Spracklen, A A Vorster, L Ramma, S Dalvie and R S Ramesar

Pharmacogenomics J 2017 17: 515-520; advance online publication, July 26, 2016; 10.1038/tpj.2016.52

Abstract | Full Text

Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer

D L Hertz, K M Kidwell, N J Seewald, C L Gersch, Z Desta, D A Flockhart, A-M Storniolo, V Stearns, T C Skaar, D F Hayes, N L Henry and J M Rae

Pharmacogenomics J 2017 17: 521-527; advance online publication, August 23, 2016; 10.1038/tpj.2016.60

Abstract | Full Text

Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer

Y Sunakawa, S Cao, N B Volz, M D Berger, D Yang, A Parekh, W Zhang, S Matsusaka, Y Ning, S Stremitzer, S Stintzing, A Sebio, S Okazaki, T Wakatsuki, M Azuma, M Watanabe, W Koizumi, A H Wu and H-J Lenz

Pharmacogenomics J 2017 17: 528-534; advance online publication, May 31, 2016; 10.1038/tpj.2016.46

Abstract | Full Text

Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis

E K Morgen, H-J Lenz, D J Jonker, D Tu, G Milano, F Graziano, J Zalcberg, C S Karapetis, A Dobrovic, C J O’Callaghan and G Liu

Pharmacogenomics J 2017 17: 535-542; advance online publication, November 29, 2016; 10.1038/tpj.2016.56

Abstract | Full Text

CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy

S Matsusaka, S Cao, D L Hanna, Y Sunakawa, M Ueno, N Mizunuma, W Zhang, D Yang, Y Ning, S Stintzing, A Sebio, S Stremitzer, S Yamauchi, A Parekh, S Okazaki, M D Berger, R El-Khoueiry, A Mendez, W Ichikawa, F Loupakis and H-J Lenz

Pharmacogenomics J 2017 17: 543-550; advance online publication, August 9, 2016; 10.1038/tpj.2016.59

Abstract | Full Text

HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy

M Frías, D Rodríguez-Cano, F Cuenca-López, J Macías, A Gordon, B Manzanares-Martín, J A Pineda, Á Camacho, J Torre-Cisneros, J Peña, A Rivero-Juárez and A Rivero

Pharmacogenomics J 2017 17: 551-555; advance online publication, May 31, 2016; 10.1038/tpj.2016.42

Abstract | Full Text

Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype

T Vanhove, P Annaert, D Lambrechts and D R J Kuypers

Pharmacogenomics J 2017 17: 556-562; advance online publication, July 5, 2016; 10.1038/tpj.2016.49

Abstract | Full Text

Retraction

Top

Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex

J S Rao, R N Ertley, H-J Lee, S I Rapoport and R P Bazinet

Pharmacogenomics J 2017 17: 563; advance online publication, October 17, 2017; 10.1038/tpj.2017.42

Full Text

 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature